I expect steady premium compounding, not an explosive
re-rating. BWXT should convert added manufacturing capacity, defense-fuel work and commercial nuclear services into faster revenue growth, but the stock already reflects scarcity value and the Erwin
enrichment project is mostly beyond this horizon. That supports continued premium status with mild multiple compression rather than a step-change.